Accueil   Diary - News   All news MaaT Pharma Presents Product Analysis

MaaT Pharma Presents Product Analysis

 

MaaT Pharma Presents Product Analysis of its First-in-class High Diversity Microbiome Therapeutic at 2018 EMBO Symposium on The Human Microbiome
 

Results from in silico analysis using MaaT Pharma’s data analysis platform, GutPrint, demonstrate therapeutic rationale and manufacturing capabilities of developing a high diversity biological drug product.

 

 

Read the press release